Physician profile
Albert Devon Sam
NPI 1396736971
$3,377.62
in general payments reported to CMS, 2019-2025
14 companies · $1,306 in 2025
The $1,306 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $433 · 2021: $360 · 2022: $471 · 2023: $216 · 2025: $1,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $943 · Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $942.51 |
| Food and Beverage | $580.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,405.98 | 2019-2025 | Ekosonic, General - Balloons, General - Angiography |
| Janssen Pharmaceuticals, INC | $517.94 | 2019-2023 | Xarelto |
| Cook Medical LLC | $322.52 | 2019-2023 | Zenith Alpha |
| Inari Medical, INC. | $242.78 | 2020 | |
| Silk Road Medical, INC. | $204.01 | 2020-2021 | |
| Cardiovascular Systems INC. | $160.60 | 2019-2022 | |
| Medtronic, INC. | $142.35 | 2021-2022 | |
| Organogenesis INC. | $126.88 | 2022 | |
| W. L. Gore & Associates, INC. | $100.00 | 2020 | |
| Osiris Therapeutics INC. | $47.28 | 2019 | |
| Medtronic Vascular, INC. | $34.74 | 2019 | |
| Lemaitre Vascular, INC. | $29.76 | 2019 | |
| Bard Peripheral Vascular, INC. | $23.07 | 2020 | |
| Tactile Systems Technology INC | $19.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Sam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.